148 related articles for article (PubMed ID: 38728069)
1. Giving a Voice to Patients With Smell Disorders Associated With COVID-19: Cross-Sectional Longitudinal Analysis Using Natural Language Processing of Self-Reports.
Menger NS; Tognetti A; Farruggia MC; Mucignat C; Bhutani S; Cooper KW; Rohlfs Domínguez P; Heinbockel T; Shields VDC; D'Errico A; Pereda-Loth V; Pierron D; Koyama S; Croijmans I
JMIR Public Health Surveill; 2024 May; 10():e47064. PubMed ID: 38728069
[TBL] [Abstract][Full Text] [Related]
2. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss.
Ohla K; Veldhuizen MG; Green T; Hannum ME; Bakke AJ; Moein ST; Tognetti A; Postma EM; Pellegrino R; Hwang DLD; Albayay J; Koyama S; Nolden AA; Thomas-Danguin T; Mucignat-Caretta C; Menger NS; Croijmans I; Ã-ztà Rk L; YanÄ K H; Pierron D; Pereda-Loth V; Nunez-Parra A; Martinez Pineda AM; Gillespie D; Farruggia MC; Cecchetto C; Fornazieri MA; Philpott C; Voznessenskaya V; Cooper KW; Rohlfs Dominguez P; Calcinoni O; de Groot J; Boesveldt S; Bhutani S; Weir EM; Exten C; Joseph PV; Parma V; Hayes JE; Niv MY
Rhinology; 2022 Jun; 60(3):207-217. PubMed ID: 35398877
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and correlates of parosmia and phantosmia among smell disorders.
Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
[TBL] [Abstract][Full Text] [Related]
4. Post-COVID syndrome: analysis of the prevalence of chemosensory dysfunction and predictive factors of recovery in COVID-19 long-haulers in Jordan.
Sawan HM; Khalifeh AH; Ahmed M; Khalil MM; Al Omari SM; Binsuwaidan R
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2593-2604. PubMed ID: 38567618
[TBL] [Abstract][Full Text] [Related]
5. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Long Haulers of COVID-19: Mixed Methods Analysis of YouTube Content.
Jordan A; Park A
JMIR AI; 2024 Jun; 3():e54501. PubMed ID: 38875666
[TBL] [Abstract][Full Text] [Related]
7. Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions.
Rogn Å; Jensen JL; Iversen PO; Singh PB
Sci Rep; 2024 Feb; 14(1):3455. PubMed ID: 38342941
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis.
Parma V; Ohla K; Veldhuizen MG; Niv MY; Kelly CE; Bakke AJ; Cooper KW; Bouysset C; Pirastu N; Dibattista M; Kaur R; Liuzza MT; Pepino MY; Schöpf V; Pereda-Loth V; Olsson SB; Gerkin RC; Rohlfs Domínguez P; Albayay J; Farruggia MC; Bhutani S; Fjaeldstad AW; Kumar R; Menini A; Bensafi M; Sandell M; Konstantinidis I; Di Pizio A; Genovese F; Öztürk L; Thomas-Danguin T; Frasnelli J; Boesveldt S; Saatci Ö; Saraiva LR; Lin C; Golebiowski J; Hwang LD; Ozdener MH; Guàrdia MD; Laudamiel C; Ritchie M; Havlícek J; Pierron D; Roura E; Navarro M; Nolden AA; Lim J; Whitcroft KL; Colquitt LR; Ferdenzi C; Brindha EV; Altundag A; Macchi A; Nunez-Parra A; Patel ZM; Fiorucci S; Philpott CM; Smith BC; Lundström JN; Mucignat C; Parker JK; van den Brink M; Schmuker M; Fischmeister FPS; Heinbockel T; Shields VDC; Faraji F; Santamaría E; Fredborg WEA; Morini G; Olofsson JK; Jalessi M; Karni N; D'Errico A; Alizadeh R; Pellegrino R; Meyer P; Huart C; Chen B; Soler GM; Alwashahi MK; Welge-Lüssen A; Freiherr J; de Groot JHB; Klein H; Okamoto M; Singh PB; Hsieh JW; ; Reed DR; Hummel T; Munger SD; Hayes JE
Chem Senses; 2020 Oct; 45(7):609-622. PubMed ID: 32564071
[TBL] [Abstract][Full Text] [Related]
10. [Parosmia and phantosmia: clinical update].
Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
[TBL] [Abstract][Full Text] [Related]
11. Phantom smells: a prevalent COVID-19 symptom that progressively sets in.
Bousquet C; Bouchoucha K; Bensafi M; Ferdenzi C
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1219-1229. PubMed ID: 36173444
[TBL] [Abstract][Full Text] [Related]
12. Phantosmia May Predict Long-Term Measurable Olfactory Dysfunction After COVID-19.
Leung JS; Cordano VP; Fuentes-López E; Lagos AE; García-Huidobro FG; Aliaga R; Díaz LA; García-Salum T; Salinas E; Toro A; Callejas CA; Riquelme A; Palmer JN; Medina RA; González G C
Laryngoscope; 2022 Dec; 132(12):2445-2452. PubMed ID: 36149773
[TBL] [Abstract][Full Text] [Related]
13. Hyperosmia after COVID-19: hedonic perception or hypersensitivity?
Di Stadio A; D'Ascanio L; De Luca P; Roccamatisi D; La Mantia I; Brenner MJ
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2196-2200. PubMed ID: 35363370
[TBL] [Abstract][Full Text] [Related]
14. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
[TBL] [Abstract][Full Text] [Related]
15. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013876. PubMed ID: 34291813
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Taste and Smell Outcomes After COVID-19.
Sharetts R; Moein ST; Khan R; Doty RL
JAMA Netw Open; 2024 Apr; 7(4):e247818. PubMed ID: 38652477
[TBL] [Abstract][Full Text] [Related]
18. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination.
Hernandez AK; Landis BN; Altundag A; Fjaeldstad AW; Gane S; Holbrook EH; Huart C; Konstantinidis I; Lechner M; Macchi A; Portillo Mazal P; Miwa T; Philpott CM; Pinto JM; Poletti SC; Vodicka J; Welge-Luessen A; Whitcroft KL; Hummel T
ORL J Otorhinolaryngol Relat Spec; 2023; 85(6):312-320. PubMed ID: 37062268
[TBL] [Abstract][Full Text] [Related]
19. Objective evaluation of odor loss in COVID-19 and other suspected cases.
Seden N; Yiğit E; Yiğit Ö; Kaygısız İ
Am J Otolaryngol; 2021; 42(1):102761. PubMed ID: 33080550
[TBL] [Abstract][Full Text] [Related]
20. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic.
Hopkins C; Surda P; Vaira LA; Lechien JR; Safarian M; Saussez S; Kumar N
Rhinology; 2021 Feb; 59(1):26-31. PubMed ID: 33320115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
